Indoco Remedies Limited (INDOCO.NS)
- Previous Close
251.86 - Open
254.80 - Bid --
- Ask --
- Day's Range
250.00 - 255.10 - 52 Week Range
190.00 - 387.55 - Volume
44,910 - Avg. Volume
96,868 - Market Cap (intraday)
23.163B - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
-- - EPS (TTM)
-1.59 - Earnings Date May 22, 2025
- Forward Dividend & Yield 1.50 (0.60%)
- Ex-Dividend Date Sep 19, 2024
- 1y Target Est
291.20
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infectives, vitamins/minerals/nutrients, ophthal/ontological, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, as well as anti-haemorrhoidal creas and calcium preparations. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company also exports its products. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
www.indoco.com6,000
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: INDOCO.NS
View MorePerformance Overview: INDOCO.NS
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INDOCO.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INDOCO.NS
View MoreValuation Measures
Market Cap
23.28B
Enterprise Value
31.18B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.27
Price/Book (mrq)
2.13
Enterprise Value/Revenue
1.84
Enterprise Value/EBITDA
17.84
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.62%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
17.24B
Net Income Avi to Common (ttm)
-106.6M
Diluted EPS (ttm)
-1.59
Balance Sheet and Cash Flow
Total Cash (mrq)
417.3M
Total Debt/Equity (mrq)
76.63%
Levered Free Cash Flow (ttm)
--